| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| HOLUBIAK MYRON Z | Vice Chairman, Director | C/O CITIUS PHARMACEUTICALS, INC., 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD | /s/ Alexander M. Donaldson, by power of attorney | 12 Aug 2025 | 0001199080 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CTXR | Common Stock | 79.7K | 08 Aug 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CTXR | Warrant to Purchase Common Stock | Disposed to Issuer | -31.4K | -100% | 0 | 08 Aug 2025 | Common Stock | 31.4K | $28.75 | Direct | F1 | ||
| transaction | CTXR | Warrant to Purchase Common Stock | Award | +31.4K | 31.4K | 08 Aug 2025 | Common Stock | 31.4K | $28.75 | Direct | F1 | |||
| transaction | CTXR | Warrant to Purchase Common Stock | Disposed to Issuer | -22.3K | -100% | 0 | 08 Aug 2025 | Common Stock | 22.3K | $19.25 | Direct | F2 | ||
| transaction | CTXR | Warrant to Purchase Common Stock | Award | +22.3K | 22.3K | 08 Aug 2025 | Common Stock | 22.3K | $19.25 | Direct | F2, F4 | |||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 14K | 08 Aug 2025 | Common Stock | 14K | $9.50 | Direct | F3 | |||||
| holding | CTXR | Stock Option (Right to Buy) | 3K | 08 Aug 2025 | Common Stock | 3K | $9.50 | See footnote | F4 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 16K | 08 Aug 2025 | Common Stock | 16K | $17.50 | Direct | F5 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 16K | 08 Aug 2025 | Common Stock | 16K | $31.25 | Direct | F6 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 26K | 08 Aug 2025 | Common Stock | 26K | $51.00 | Direct | F7 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 600 | 08 Aug 2025 | Common Stock | 600 | $51.00 | See footnote | F4 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 12K | 08 Aug 2025 | Common Stock | 12K | $50.00 | Direct | F7 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 400 | 08 Aug 2025 | Common Stock | 400 | $50.00 | See footnote | F4 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 8K | 08 Aug 2025 | Common Stock | 8K | $25.25 | Direct | F7 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 7K | 08 Aug 2025 | Common Stock | 7K | $16.75 | Direct | F7 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 6K | 08 Aug 2025 | Common Stock | 6K | $40.50 | Direct | F7 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 1.6K | 08 Aug 2025 | Common Stock | 1.6K | $86.25 | Direct | F7 | |||||
| holding | CTXR | Stock Option (Right to Purchase Common Stock) | 1.07K | 08 Aug 2025 | Common Stock | 1.07K | $202.50 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately. |
| F2 | The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately. |
| F3 | The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. |
| F4 | The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares. |
| F5 | The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. |
| F6 | The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. |
| F7 | The options are vested in full and exercisable immediately. |
All share amounts reflect the 1-for-25 reverse stock split effective November 22, 2024.